ClinicalTrials.Veeva

Menu

Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal

U

Unidade Local De Saúde Do Norte Alentejano

Status

Completed

Conditions

Stomach Cancer
Gastric Cancer (Diagnosis)

Study type

Observational

Funder types

Other

Identifiers

NCT07387237
MGPT Gastric Cancer (Other Identifier)

Details and patient eligibility

About

Multigene germeline panel test in gastric cancer patients

Full description

We conducted a retrospective observational study including 51 patients with histologically confirmed gastric cancer who underwent MGPT between 2020 and 2025. Genetic testing was performed using validated 15 or 30 gene panels. Clinical, pathological, and survival data were retrieved from medical records.

Enrollment

51 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Eligible participants were adults (≥18 years) with histologically confirmed gastric adenocarcinoma who underwent MGPT between 2020 and 2025;
  • Ability to understand Portuguese and/or English;
  • Ability to provide valid informed consent.

Exclusion Criteria:

  • All patients who met eligibility and inclusion criteria were included in the study;
  • Patients without a definitive genetic report or with incomplete clinical data for key study variables were excluded.

Trial design

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems